M
MNOV
Medicinova
1.400
+0.030+2.19%After Hours: 1.380 -0.020 -1.41%18:45 05/22 EDT
OPEN/PREV CLOSE1.400/1.370
TODAY RANGE1.379-1.450
VOL12.79K
MARKET CAP68.91M
52 WEEK RANGE1.168-1.960
AVG VOL (3M)44.45K
% TURNOVER0.03%
TURNOVER--
P/E (TTM)-5.8651
% RANGE5.18%
EPS(TTM)-0.2387
P/E(FORWARD)-5.3846
P/B1.749
BVPS0.8006
DIVIDEND--
P/S168.67
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP66.93M
SHARES OUTSTANDING49.22M
NEXT EARNINGS08/11-08/17
FREE FLOAT47.81M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Barchart·05/14 17:44
MediciNova: Q1 Earnings Snapshot
Dow Jones·05/04 13:42
MediciNova Is Maintained at Buy by D. Boral Capital
TipRanks·04/27 23:15
MediciNova’s peer-reviewed ibudilast study advances clinical translation
TipRanks·03/23 13:47
Super Micro downgraded, MongoDB upgraded: Wall Street’s top analyst calls
Dow Jones·03/23 12:59
MediciNova Price Target Announced at $6.00/Share by Maxim Group
TipRanks·03/23 12:45
Maxim resumes MediciNova at Buy on potential value-driving data events this year
TipRanks·03/23 11:36
MediciNova resumed with a Buy at Maxim
Benzinga·03/16 12:57
This Qualcomm Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
Benzinga·03/16 11:37
This Cohu Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Dow Jones·03/16 11:26
MediciNova Price Target Announced at $10.00/Share by HC Wainwright & Co.
Dow Jones·03/16 11:26
MediciNova Initiated at Buy by HC Wainwright & Co.
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.